{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:32:13Z","timestamp":1792794733596,"version":"4.5.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009980","name":"Medical University of Innsbruck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009980","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167146","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T13:51:16Z","timestamp":1480600276000},"page":"e0167146","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":78,"title":["Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk"],"prefix":"10.1371","volume":"11","author":[{"given":"Benedikt","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"W\u00fcrtinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Finkenstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Effenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Sulzbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Moschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Griesmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"S Kulnigg","year":"2008","journal-title":"The American journal of gastroenterology"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3109\/00365521.2015.1031168","article-title":"A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease","volume":"50","author":"W Reinisch","year":"2015","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ecco-jcc\/jju009","article-title":"European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases","volume":"9","author":"AU Dignass","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2141.2011.09012.x","article-title":"UK guidelines on the management of iron deficiency in pregnancy","volume":"156","author":"S Pavord","year":"2012","journal-title":"British journal of haematology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40265-014-0332-3","article-title":"Ferric carboxymaltose: a review of its use in iron deficiency","volume":"75","author":"GM Keating","year":"2015","journal-title":"Drugs"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1053\/j.gastro.2011.06.005","article-title":"FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease","volume":"141","author":"R Evstatiev","year":"2011","journal-title":"Gastroenterology"},{"key":"ref7","unstructured":"New Drug Application (NDA) 22\u2013054 for Injectafer (Ferric Carboxymaltose) for the treatment of iron deficiency anemia in patients with heavy uterine bleeding or postpartum patients FDA Advisory Committee Briefing Document. 2008."},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"DB Van Wyck","year":"2009","journal-title":"Transfusion"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/trf.12289","article-title":"A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia","volume":"54","author":"JE Onken","year":"2014","journal-title":"Transfusion"},{"key":"ref10","unstructured":"Soeren AS, Claes CS, Lars LT. Phosphate levels after iron isomaltoside administration. Poster European Iron Club Meeting 2016, Innsbruck. 2016."},{"issue":"6","key":"ref11","first-page":"284","article-title":"Hypophosphatemia, a poorly known adverse reaction of intravenous use of iron","volume":"143","author":"Mendoza JA Barea","year":"2014","journal-title":"Medicina clinica"},{"issue":"1","key":"ref12","first-page":"49","article-title":"Severe hypophosphataemia after intravenous iron administration","volume":"72","author":"A Blazevic","year":"2014","journal-title":"The Netherlands journal of medicine"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ejcn.2014.20","article-title":"Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient","volume":"68","author":"YC Fierz","year":"2014","journal-title":"European journal of clinical nutrition"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/TP.0b013e3181f00a18","article-title":"Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient","volume":"90","author":"LY Mani","year":"2010","journal-title":"Transplantation"},{"issue":"2","key":"ref15","first-page":"165","article-title":"Uncommon adverse effect of a common medication","volume":"133","author":"KL Moore","year":"2013","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"105","key":"ref16","first-page":"61","article-title":"Hypophosphat\u00e9mie et FGF23 \u00e9lev\u00e9","volume":"12","author":"N Poursac","year":"2015","journal-title":"Rhumatos"},{"key":"ref17","first-page":"843689","article-title":"Potentially life-threatening phosphate diabetes induced by ferric carboxymaltose injection: a case report and review of the literature","volume":"2014","author":"X Vandemergel","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"ref18","article-title":"Symptomatic hypophosphataemic osteomalacia secondary to the treatment with iron carboxymaltose detected in bone scintigraphy","author":"Sahun MJ Sangros","year":"2016","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"M Wolf","year":"2013","journal-title":"Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000447020.74593.6f","article-title":"Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease","volume":"23","author":"M Wolf","year":"2014","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref21","unstructured":"National Cancer Institute Common Terminology Criteria for Adverse Events v4.0 NCI, NIH, DHHS. NIH publication. 2009; # 09\u20137473."},{"issue":"302","key":"ref22","first-page":"439","article-title":"Clinical and histological spectrum of osteomalacia among Asians in south London","volume":"83","author":"PJ Finch","year":"1992","journal-title":"Q J Med"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0002-9343(99)00460-X","article-title":"Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption","volume":"108","author":"B Basha","year":"2000","journal-title":"The American journal of medicine"},{"issue":"46","key":"ref24","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"EG Farrow","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref25","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","author":"V David","year":"2015","journal-title":"Kidney international"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T19:16:57Z","timestamp":1718911017000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167146"}},"subtitle":[],"editor":[{"given":"Kostas","family":"Pantopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167146","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}